Effects of immunomodulatory drugs on TNF-α and IL-12 production by purified epidermal langerhans cells and peritoneal macrophages

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Campelo, Simone R ^a   Da Silva, Moises B ^a   Vieira, José Lf ^a   Da Silva, Jorge P ^a   Salgado, Claudio G ^a  

^a Federal University of Pa   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 79251576460     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-24     Document Type: Article

References (35)

1. Taking dendritic cells into medicine. RM Steinman J Banchere (Pubitemid 47509552)
2. Langerhans cells at the interface of medicine, science, and industry. M Merad N Romani G Randolph, J Invest Dermatol 2008 128 251 255 10.1038/sj.jid.5701229 18195738
3. The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells? RE Callard JI Harper, Trends Immunol 2007 28 294 298 10.1016/j.it.2007. 05.003 17544846 (Pubitemid 46964900)
4. Langerhans cells: mediators of immunity and tolerance. CL Berger JG Vasquez J Shofner K Mariwalla RL Edelson, Int J Biochem Cell Biol 2006 38 1632 1636 10.1016/j.biocel.2006.03.006 16697242 (Pubitemid 43947648)
5. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. H Fujita A Asahina M Sugaya K Nakamura P Gao H Fujiwara K Tamaki, J Invest Dermatol 2005 124 343 350 10.1111/j.0022-202X.2004.23607.x 15675953 (Pubitemid 40175881)
6. Differential effects of LPS and TGF-beta on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, and macrophages. Y Tada A Asahina H Fujita H Mitsui H TORII T Watanabe K Tamaki, Cytokine 2004 25 155 161 10.1016/j.cyto.2003.11.006 15162832 (Pubitemid 38177258)
7. The biology of IL-12: coordinating innate and adaptive immune responses. WT Watford M Moriguchi A Morinobu JJ O'Shea, Cytokine Growth Factor Rev 2003 14 361 368 10.1016/S1359-6101(03)00043-1 12948519 (Pubitemid 37099449)
8. Interleukin-10 and related cytokines and receptors. S Pestka CD Krause D Sarkar MR Walter Y Shi PB Fisher, Annu Rev Immunol 2004 22 929 979 10.1146/annurev.immunol.22.012703.104622 15032600 (Pubitemid 38680445)
9. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. P Blanco AK Palucka V Pascual J Banchereau, Cytokine Growth Factor Rev 2008 19 41 52 10.1016/j.cytogfr.2007.10.004 18258476
10. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. H Hackstein AW Thomson, Nat Rev Immunol 2004 4 24 34 10.1038/nri1256 14704765 (Pubitemid 38084129)
11. Functional CD40 ligand is expressed on epidermal Langerhans cells. CG Salgado K Nakamura M Sugaya Y Tada A Asahina Y Koyama S Irie K Tamaki, J Leukoc Biol 1999 66 281 285 10449168 (Pubitemid 29379169)
12. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. HY Kim JR Kim HS Kim, J Microbiol Biotechnol 2008 18 1170 1178 18600064
13. Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells. TL Rowland SM McHugh J Deighton RJ Dearman PW Ewan I Kimber, Immunopharmacology 1998 40 11 20 10.1016/S0162-3109(98)00010-1 9776474 (Pubitemid 28434949)
14. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells. CG Salgado K Nakamura M Sugaya Y Tada A Asahina S Fukuda Y Koyama S Irie K Tamaki, J Invest Dermatol 1999 113 1021 1027 10.1046/j.1523-1747.1999.00785.x 10594746 (Pubitemid 30013347)
15. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. Y Tada A Asahina K Nakamura M Tomura H Fujiwara K Tamaki, J Immunol 2000 164 5113 5119 10799868 (Pubitemid 30305185)
16. Dendritic cells: biology of the skin. MJ Toebak S Gibbs DP Bruynzeel RJ Scheper T Rustemeyer, Contact Dermatitis 2009 60 2 20 10.1111/j.1600-0536.2008. 01443.x 19125717
17. Dendritic cells in the skin - potential use for melanoma treatment. S El Marsafy M Bagot A Bensussan A Mauviel, Pigment Cell Melanoma Res 2009 22 30 41 10.1111/j.1755-148X.2008.00532.x 19040502
18. Dendritic cells as a target of immunosuppressive drugs. C Van Kooten AM Woltman, Transplantation Review 2004 18 70 79 10.1016/j.trre.2004.04.002 (Pubitemid 38950335)
19. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. AM Woltman JW de Fijter SW Kamerling LC Paul MR Daha C Van Kooten, Eur J Immunol 2000 30 1807 1812 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N 10940869 (Pubitemid 30456176)
20. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. D Franchimont H Martens MT Hagelstein E Louis W Dewe GP Chrousos J Belaiche V Geenen, J Clin Endocrinol Me tab 1999 84 2834 2839 10.1210/jc.84.8.2834 (Pubitemid 30642019)
21. Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages. M Frankenberger K Haussinger L Ziegler-Heitbrock, Int Immunopharmacol 2005 5 289 299 10.1016/j.intimp.2004.09. 033 15652760 (Pubitemid 40126355)
22. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. RH DeKruyff Y Fang DT Umetsu, J Immunol 1998 160 2231 2237 9498762 (Pubitemid 28119903)
23. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells. L Deng W Ding RD Granstein, J Invest Dermatol 2003 121 1060 1065 10.1046/j.1523-1747.2003.12565.x 14708607 (Pubitemid 37430974)
24. Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factor-kappaB. SC Paul P Lv YJ Xiao P An SQ Liu HS Luo, Pathobiology 2006 73 82 92 10.1159/000094492 16943688 (Pubitemid 44319502)
25. Inhibition of IL-12 production by thalidomide. DR Moller M Wysocka BM Greenlee X Ma L Wahl DA Flockhart G Trinchieri CL Karp, J Immunol 1997 159 5157 5161 9366446 (Pubitemid 127471057)
26. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease. J Bauditz S Wedel H Lochs, Gut 2002 50 196 200 10.1136/gut.50.2.196 11788559 (Pubitemid 34087931)
27. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking. M Peiser R Wanner G Kolde, J Leukoc Biol 2004 15178702
28. Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells. JE Garcia MR de Cabo FM Rodriguez JP Losada AJ Lopez JL Arellano, Mediators Inflamm 2000 9 169 174 10.1080/09629350020008682 11132774
29. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. K Tajima R Amakawa T Ito M Miyaji M Takebayashi S Fukuhara, Immunology 2003 108 321 328 10.1046/j.1365-2567.2003.01585.x 12603598 (Pubitemid 36332390)
30. Cyclosporin A and FK506 inhibit IL-12p40 production through the calmodulin/calmodulin-dependent protein kinase-activated phosphoinositide 3-kinase in lipopolysaccharide-stimulated human monocytic cells. W Ma S Mishra K Gee JP Mishra D Nandan NE Reiner JB Angel A Kumar, J Biol Chem 2007 282 13351 13362 10.1074/jbc.M611522200 17347151 (Pubitemid 47100546)
31. Inhibited differentiation of Langerhans cells in the rat epidermis upon systemic treatment with cyclosporin A. MB Borghi-Cirri R Riccardi-Arbi S Bacci M Mori N Pimpinelli P Romagnoli F Filipponi, Histol Histopathol 2001 16 107 112 11193184 (Pubitemid 32094028)
32. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Z Xia JW DePierre L Nassberger, Immunopharmacology 1996 34 27 37 10.1016/0162-3109(96) 00111-7 8880223 (Pubitemid 26284175)
33. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. E Obuchowicz J Kowalski K Labuzek R Krysiak J Pendzich ZS Herman, Int J Neuropsychopharmacol 2006 9 27 35 10.1017/S146114570500547X 15963243 (Pubitemid 43068332)
34. Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. M Diamond JP Kelly TJ Connor, Eur Neuropsychopharmacol 2006 16 481 490 10.1016/j.euroneuro.2005.11.011 16388933 (Pubitemid 44311000)
35. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. M Maes C Song AH Lin S Bonaccorso G Kenis R De Jongh E Bosmans S Scharpe, Neuropsychopharmacology 1999 20 370 379 10.1016/S0893-133X(98)00088-8 10088138 (Pubitemid 29099768)